• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Argos Therapeutics Inc

+ Add to Watchlist

ARGS:US

8.7000 USD 0.2300 2.58%

As of 20:10:00 ET on 12/17/2014.

Snapshot for Argos Therapeutics Inc (ARGS)

Open: 8.9000 Day's Range: 8.6501 - 8.9599 Volume: 25,024
Previous Close: 8.9300 52wk Range: 5.6113 - 13.7400 1-Yr Rtn: -

Stock Chart for ARGS

No chart data available.
  • ARGS:US 8.7000
  • 1D
  • 1M
  • 1Y
8.9300
Interactive ARGS Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ARGS

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -38.0162
Est. EPS (USD) (12/2014) -2.9770
Est. PEG Ratio -
Market Cap (M USD) 171.00
Shares Outstanding (M) 19.66
30 Day Average Volume 44,438
Price/Book (mrq) 3.6627
Price/Sale (ttm) 2.7654
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/27/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ARGS

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ARGS

Argos Therapeutics, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infectious diseases based on its proprietary technology platform.

Hubert BirnerChairmanJeffrey D AbbeyPresident/CEO
Frederick M MiesowiczVP:Manufacturing/COOCharles A NicoletteVP:Research & Dev/CSO
More Company Profile & Key Executives for ARGS

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil